Grupo Zeltia, a pharmaceutical company dedicated to the investigation of Alzheimer’s disease, required a new, international brand name for its group company, Neuropharma.
The name had to transmit the essence of the company, while supporting Grupo Zeltia going public.
We coupled the new name, Noscira, (which in etymological terms conveys the search for knowledge) with a fresh visual identity. The creation of a logotype, secondary graphics, and its application in different communication elements, reveal a place where investigation occurs, and evoke the reflective nature of the company.
The launch of the new name captured instant interest from the media. As the only Spanish biotechnology company to have reached the clinical development stage with a drug to fight Alzheimer's disease, Noscira is poised for continued success.